Clinical ResearchPost-Infarction Myocardial Perfusion ImagingA Multinational Study to Establish the Value of Early Adenosine Technetium-99m Sestamibi Myocardial Perfusion Imaging in Identifying a Low-Risk Group for Early Hospital Discharge After Acute Myocardial Infarction
Post-Infarction Myocardial Perfusion Imaging
Under an Elsevier user license
open archive
Abbreviations and Acronyms
ADSPECT
adenosine technetium-99m sestamibi single-photon emission computed tomography
ACS
acute coronary syndromes
AMI
acute myocardial infarction
ANOVA
analysis of variance
CI
confidence interval
CR
coronary revascularization
ETT
exercise treadmill testing
GLM
general linear modeling
LVEF
left ventricular ejection fraction
PDS
perfusion defect size
RR
relative risk
SDS
summed difference score
SRS
summed rest score
SSS
summed stress score
TIMI
Thrombolysis In Myocardial Infarction
Cited by (0)
Funding for INSPIRE was provided by Bristol-Myers Squibb Medical Imaging, Astellas Pharma US, and Schering Plough Research Institute.
- 1
Dr. Mahmarian is on the Advisory Board for CV Therapeutics and Astellas Pharma US.
- 2
Dr. Shaw has received research grants for the END and COURAGE trials
- 3
Dr. Filipchuk received research grants for the DIAD, CCORD, and AMISCAN studies
- 4
Drs. Iskander and Henzlova are on the Speakers’ Bureau for Bristol-Myers Squibb.
Copyright © 2006 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.